Literature DB >> 12496385

CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals.

Dennis C Otero1, Amy N Anzelon, Robert C Rickert.   

Abstract

Loss of membrane-bound Ig results in the rapid onset of apoptosis in recirculating B cells. This observation implies that a competent B cell receptor (BCR) is not only required for Ag-dependent differentiation, but also for continued survival in the peripheral immune system. Expression of the B cell coreceptor, CD19, is likewise essential for key B cell differentiative events including the formation of B-1, germinal center, and marginal zone (MZ) B cells. In this study, we report that CD19 also exerts a role before Ag encounter by promoting the survival of naive recirculating B cells. This aspect of CD19 signaling was first suggested by the analysis of mixed bone marrow chimeras, wherein CD19-/- B cells fail to effectively compete with wild-type B cells to reconstitute the peripheral B cell compartment. Consistent with this observation, Bromodeoxyuridine- and CFSE-labeling studies reveal a shorter in vivo life span for CD19-/- B cells vs their wild-type counterparts. Moreover, we find that CD19 is necessary for propagation of BCR-induced survival signals and thus may contribute to homeostatic mechanisms of tonic signaling. To determine whether provision of a constitutive survival signal could compensate for the loss of CD19 in vivo, Bcl-2-transgenic mice were bred onto the CD19-/- background. Here, we observe an increase in follicular B cell numbers and selective recovery of the MZ B cell compartment. Together these findings suggest that maintenance of the follicular and MZ B cell compartments require CD19-dependent survival signals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12496385     DOI: 10.4049/jimmunol.170.1.73

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

Review 1.  New progress in the treatment of neuromyelitis optica spectrum disorder with monoclonal antibodies (Review).

Authors:  Qinfang Xie; Mengjiao Sun; Jing Sun; Ting Zheng; Manxia Wang
Journal:  Exp Ther Med       Date:  2020-12-16       Impact factor: 2.447

2.  The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic:polyribocytidylic acid.

Authors:  Yifan Ma; A Catharine Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

3.  Pivotal advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner.

Authors:  Elizabeth O Lobo; Zhifang Zhang; John E Shively
Journal:  J Leukoc Biol       Date:  2009-05-19       Impact factor: 4.962

4.  Extracellular matrix of secondary lymphoid organs impacts on B-cell fate and survival.

Authors:  Jian Song; Zerina Lokmic; Tim Lämmermann; Julia Rolf; Chuan Wu; Xueli Zhang; Rupert Hallmann; Melanie-Jane Hannocks; Nathalie Horn; Markus A Ruegg; Arnoud Sonnenberg; Elisabeth Georges-Labouesse; Thomas H Winkler; John F Kearney; Susanna Cardell; Lydia Sorokin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-11       Impact factor: 11.205

5.  CD19 as a therapeutic target in a spontaneous autoimmune polyneuropathy.

Authors:  P M Abraham; S H Quan; D Dukala; B Soliven
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 6.  Peripheral B cell subsets.

Authors:  David Allman; Shiv Pillai
Journal:  Curr Opin Immunol       Date:  2008-04-21       Impact factor: 7.486

Review 7.  The follicular versus marginal zone B lymphocyte cell fate decision.

Authors:  Shiv Pillai; Annaiah Cariappa
Journal:  Nat Rev Immunol       Date:  2009-11       Impact factor: 53.106

8.  Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy.

Authors:  Cecille D Browne; Christopher J Del Nagro; Matthew H Cato; Hart S Dengler; Robert C Rickert
Journal:  Immunity       Date:  2009-11-05       Impact factor: 31.745

9.  T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells.

Authors:  Eugenia Zah; Meng-Yin Lin; Anne Silva-Benedict; Michael C Jensen; Yvonne Y Chen
Journal:  Cancer Immunol Res       Date:  2016-04-08       Impact factor: 11.151

Review 10.  Augmentation of antibody responses by retinoic acid and costimulatory molecules.

Authors:  A Catharine Ross; Qiuyan Chen; Yifan Ma
Journal:  Semin Immunol       Date:  2008-09-25       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.